STOCK TITAN

GE HealthCare exec has 856 shares withheld for tax

CEO of GE HealthCare’s AIS segment reported share withholding to cover taxes on vested restricted stock units.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) disclosed that Philip Rackliffe, CEO, AIS, reported three dispositions of common stock on September 1, 2026. A total of 856 shares of common stock were withheld at $71.23 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units. These are reported as payments of tax liability by delivering or withholding securities, not as open‑market sales, and no Rule 10b5-1 trading plan is indicated.

Positive

  • None.

Negative

  • None.
Insider Rackliffe Philip
Role CEO, AIS
Type Security Shares Price Value
Tax Withholding Common Stock, par value $0.01 per share F1 290 $71.23 $21K
Tax Withholding Common Stock, par value $0.01 per share F1 226 $71.23 $16K
Tax Withholding Common Stock, par value $0.01 per share F1 340 $71.23 $24K
Holdings After Transaction: Common Stock, par value $0.01 per share — 42,331 shares (Direct)
Footnotes (1)
  1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Shares withheld for taxes (first transaction) 290 shares Common stock withheld on September 1, 2026 to satisfy tax withholding obligations
Shares withheld for taxes (second transaction) 226 shares Common stock withheld on September 1, 2026 to satisfy tax withholding obligations
Shares withheld for taxes (third transaction) 340 shares Common stock withheld on September 1, 2026 to satisfy tax withholding obligations
Total shares withheld for taxes 856 shares Sum of three tax-withholding dispositions on September 1, 2026
Per-share value used for withholding $71.23 per share Applied to each withholding transaction for GE HealthCare common stock
restricted stock units financial
"in connection with the vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to satisfy tax withholding obligations in connection with the vesting"
withholding of shares financial
"Withholding of shares of GE HealthCare Technologies Inc. common stock"
Form 4 regulatory
"reported in this Form 4 insider transaction disclosure"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What did GEHC insider Philip Rackliffe report in this Form 4?

Philip Rackliffe, CEO, AIS of GE HealthCare Technologies Inc., reported three dispositions of common stock on September 1, 2026, totaling 856 shares withheld to cover tax withholding obligations related to the vesting of restricted stock units.

How many GEHC shares were involved in the tax withholding transactions?

The Form 4 reports 856 shares of GE HealthCare Technologies Inc. common stock disposed of through withholding to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

At what price were the GEHC shares valued for the tax withholding?

Each of the reported withholding transactions used a share value of $71.23 per share for GE HealthCare Technologies Inc. common stock when satisfying the tax withholding obligations tied to restricted stock unit vesting.

Were Philip Rackliffe’s GEHC transactions open-market sales?

No. All three reported transactions are coded as F, described as payment of tax liability by delivering or withholding securities, and the footnote states they are withholding of shares to satisfy tax obligations on restricted stock unit vesting, not open-market sales.

Was a Rule 10b5-1 trading plan involved in this GEHC Form 4?

No. The Form 4 indicates no Rule 10b5-1 plan for these transactions, and the only footnote describes withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations on restricted stock unit vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rackliffe Philip

(Last)(First)(Middle)
500 W. MONROE STREET

(Street)
CHICAGO ILLINOIS 60661

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO, AIS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share09/01/2026F290(1)D$71.2342,897D
Common Stock, par value $0.01 per share09/01/2026F226(1)D$71.2342,671D
Common Stock, par value $0.01 per share09/01/2026F340(1)D$71.2342,331D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)